Supreme Court Upholds Summons in Misbranding and Sub‑standard Drug Cases, Allows Prosecution to Proceed

A bench of Justices Ahsanuddin Amanullah and S.V.N. Bhatti heard consolidated appeals arising from High Court orders that had quashed criminal complaints alleging misbranding of vaccines and sale of sub‑standard syringes. The appeals raised two core legal questions: whether the limitation period barred prosecution under Sections 468–469 read with Section 473 of the Code of Criminal Procedure, 1973 (CrPC), and whether a Magistrate was obliged under Section 202 CrPC to postpone issuance of process where the accused resided outside his territorial jurisdiction, particularly where the complaint was filed by a public servant under the Drugs & Cosmetics Act, 1940.

The Court allowed the State’s appeals and set aside the High Court’s quashing order in the Panacea Biotec matter, holding that the limitation period began when the identity of the accused became known to the competent authority and that the Magistrate’s summoning order dated 10.07.2012 was valid. The Court observed that the prosecution initiated by an Inspector under Section 32 of the Drugs & Cosmetics Act satisfied statutory requirements and that the proviso to Section 200 CrPC and the precedent in Cheminova India Limited warranted a different approach where a public servant filed the complaint. The Court, in its reasoning, observed: “18. The legislature in its wisdom has itself placed the public servant on a different pedestal, as would be evident from a perusal of proviso to Section 200 of the Code of Criminal Procedure. Object of holding an inquiry/investigation before taking cognizance, in cases where the accused resides outside the territorial jurisdiction of such Magistrate, is to ensure that innocents are not harassed unnecessarily. By virtue of proviso to Section 200 of the Code of Criminal Procedure, the Magistrate, while taking cognizance, need not record statement of such public servant, who has filed the complaint in discharge of his official duty. Further, by virtue of Section 293 of Code of Criminal Procedure, report of the Government Scientific Expert is, per se, admissible in evidence. The Code of Criminal Procedure itself provides for exemption from examination of such witnesses, when the complaint is filed by a public servant.” The Court also held that “the Impugned Order is set aside, and the Order taking cognisance and issuing summons dated 10.07.2012 is held to be good in law.”

Background
The disputes arose from two factual matrices. In the first, a 2005 complaint and subsequent enquiries by the Drugs Inspector alleged that cartons of a pentavalent vaccine bore labels (Easy Five) inconsistent with vial labels (Easy Four), amounting to misbranding under Sections 17(b), 17(c) and 18(a)(i) of the Drugs & Cosmetics Act, punishable under Section 27(d). The Drugs Inspector conducted inspections, seized invoices and obtained statements suggesting wrongly labelled vials were sold and returned to suppliers. The CJM condoned delay under Section 473 CrPC and issued summons in 2009 and 2012; the High Court quashed proceedings on territorial‑jurisdiction and Section 202 grounds. The State challenged that order before the Supreme Court.

In the second, samples of single‑use syringes drawn by a Drugs Inspector tested “not of standard quality” by the Government Analyst; a trial court complaint named the manufacturer and directors under Section 18(a)(i). The High Court quashed that complaint partly on Section 202 non‑compliance and on sufficiency under Section 34 of the Act; the State appealed.

The Supreme Court analysed limitation law under Sections 468–469 CrPC and held limitation ran from the date the identity of accused became known to the competent authority (here, 18.04.2006), so the complaint filed on 20.01.2009 remained within the three‑year period. On jurisdiction under Section 202, the Court read Section 202 harmoniously with the proviso to Section 200 and followed Cheminova, concluding that a complaint by an Inspector in discharge of official duty did not attract the same mandatory examination/postponement regime as private complaints. The Court remanded matters to the trial courts, directed substitution of persons in charge where a Managing Director had died, and ordered fresh summons to be issued; it observed that its conclusions did not constitute final adjudication on merits and parties remained free to raise factual and legal issues at trial.

Case Details:
Case No.: 2026 INSC 200
Case Title: The State of Kerala & Anr. v. M/s Panacea Biotec Ltd. & Anr.; M/s Panacea Biotec Ltd. & Anr. v. State of Kerala & Anr.; The Drugs Inspector & Anr. v. Vimal Kumar Khemkha & Anr.
Appearances:
For the Petitioner(s): H. V. Hameed (Counsel for the State/Applicants)
For the Respondent(s): Siddharth Luthra (Senior Counsel for Respondents)

Source: 2026 CaseBase(SC) 177